Literature DB >> 7978579

Fluoxetine and the serotonin syndrome.

F Ruiz1.   

Abstract

A 48-year-old man presented to the emergency department with confusion, agitation, diaphoresis, and muscle rigidity after beginning treatment with fluoxetine, a serotonin reuptake inhibitor. He had discontinued treatment with tranylcypromine, a monoamine oxidase inhibitor, 2 weeks earlier. The constellation of findings was diagnostic of the serotonin syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978579     DOI: 10.1016/s0196-0644(94)70218-7

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

1.  Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods.

Authors:  Sarah J Yates; Niraj Ahuja; Sarah E Gartside; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2011-08

Review 2.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

3.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 4.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

5.  Drug-induced hypertension.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.